- Home
- TELA vs VRCA Comparison
TELA vs VRCA Comparison
Compare TELA & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- VRCA
- Stock Information
- Founded
- TELA 2012
- VRCA 2013
- Country
- TELA United States
- VRCA United States
- Employees
- TELA N/A
- VRCA N/A
- Industry
- TELA Medical/Dental Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- TELA Health Care
- VRCA Health Care
- Exchange
- TELA Nasdaq
- VRCA Nasdaq
- Market Cap
- TELA 36.4M
- VRCA 43.0M
- IPO Year
- TELA 2019
- VRCA 2018
- Fundamental
- Price
- TELA $1.39
- VRCA $0.49
- Analyst Decision
- TELA Strong Buy
- VRCA Hold
- Analyst Count
- TELA 4
- VRCA 5
- Target Price
- TELA $6.00
- VRCA $6.00
- AVG Volume (30 Days)
- TELA 152.8K
- VRCA 263.8K
- Earning Date
- TELA 05-08-2025
- VRCA 05-13-2025
- Dividend Yield
- TELA N/A
- VRCA N/A
- EPS Growth
- TELA N/A
- VRCA N/A
- EPS
- TELA N/A
- VRCA N/A
- Revenue
- TELA $71,217,000.00
- VRCA $7,179,000.00
- Revenue This Year
- TELA $26.37
- VRCA $127.85
- Revenue Next Year
- TELA $22.68
- VRCA $105.09
- P/E Ratio
- TELA N/A
- VRCA N/A
- Revenue Growth
- TELA 12.78
- VRCA N/A
- 52 Week Low
- TELA $0.86
- VRCA $0.38
- 52 Week High
- TELA $6.00
- VRCA $9.36
- Technical
- Relative Strength Index (RSI)
- TELA 61.85
- VRCA 42.86
- Support Level
- TELA $1.30
- VRCA $0.49
- Resistance Level
- TELA $1.53
- VRCA $0.73
- Average True Range (ATR)
- TELA 0.13
- VRCA 0.07
- MACD
- TELA 0.04
- VRCA -0.01
- Stochastic Oscillator
- TELA 76.43
- VRCA 21.79
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.